| ［1］ RuizArgüelles GJ, RuizDelgado GJ, GarcesEisele J, et al. Donor cell leukemia after nonmyeloablative allogeneic stem cell transplantation: a single institution experience［J］. Leuk Lymphoma, 2006, 47(9): 1952-1955. DOI: 10.1080/10428190600693099.
［2］ Wiseman DH. Donor cell leukemia: a review［J］. Biol Blood Marrow Transplant, 2011, 17(6): 771-789. DOI: 10.1016/j.bbmt.2010.10.010.
［3］ RuizDelgado GJ, HernándezReyes J, GonzálezRamírez MP, et al. Donor cell leukemia (DCL): a prospective study of its identification and treatment［J］. Gac Med Mex, 2015, 151(5): 582-587.
［4］ Wang E, Hutchinson CB, Huang Q, et al. Donor cellderived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature［J］. Am J Clin Pathol, 2011, 135(4): 525-540. DOI: 10.1309/AJCPPJUQ9DNR1GHP. |
